- Published at
- by gurufocus.com
mixed
mixed
OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
”” PIKture-01 trial update including additional PK data, mature single agent and initial combination data expected in the second half of 2025; reported encoura